Hepatology - European Medical Journal

This site is intended for healthcare professionals

Continue

Hepatology

Filter
11 Mins
26 Apr 2022

The Impact of Paediatric Cholestatic Liver Disease: Diagnosis, Management, and Treatment Considerations

Cholestatic liver diseases are the leading indications for paediatric liver transplant, and result in significant morbidity and mortality.
EMJ Oncology 10 [Supplement 2] 2022 feature
14 Mins
3 Feb 2022

Optimising Cholangiocarcinoma Diagnosis and Treatment Focusing on Precision Medicine

This article is based on interviews conducted with Lorenza Rimassa, Arndt Vogel, and Harpreet Wasan. They provided their expert opinion…
EMJ Hepatology 10 [Supplement 1] 2022 Feature Image
6 Mins
13 Jan 2022

New Data on Aramchol™: Efficacy of a Higher Daily Exposure to Aramchol on Fibrosis Improvement in the ARMOR Study Open-Label Part

Non-alcoholic steatohepatitis (NASH) is the advanced form of non-alcoholic fatty liver disease, which can lead to further…
4 Mins
24 Feb 2020

New Data on Aramchol TM for the Treatment of Non-alcoholic Steatohepatitis: Exploring Potential for Greater Efficacy and the Effect on Glucose Metabolism

Aramchol is a liver-targeted, oral stearoyl coenzyme A desaturase 1 (SCD1) modulator that has been shown to reduce liver fat and fibrosis in patients…
9 Mins
28 May 2019

Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate

Clinical studies of the TPO-R agonist lusutrombopag included a large proportion of high-risk bleeding patients and therapy with this agent has been shown…
14 Mins
27 Jul 2018

Primary Biliary Cholangitis in Motion Meeting

The purpose of the meeting was to work towards unified best practice in the treatment of primary biliary cholangitis (PBC). This centred on a theme of…
10 Mins
8 Jun 2017

A Discussion on the Management of Wilson Disease

Prof Peter Ferenci opened the meeting by providing a background to Wilson disease (WD), an enigmatic condition where no two cases are the same. He explored…
10 Mins
31 May 2016

Welcome to the Real World: Hepatitis C Virus Clinical Trials to Patient Realities

The symposium addressed the efficacy and safety of compounds currently available for treatment of hepatitis C virus (HCV) and chronic kidney disease…
We’ve noticed you’re accessing
from North/South America.